Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on 'Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of Warning Letters'

@article{Doran2016TroubleSI,
  title={Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on 'Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of Warning Letters'},
  author={E. Doran},
  journal={Legal Perspectives in Information Systems eJournal},
  year={2016}
}
  • E. Doran
  • Published 2016
  • Medicine
  • Legal Perspectives in Information Systems eJournal
Hyosun Kim's report "Trouble Spots in Online Direct to Consumer Prescription Drug Promotion: A content Analysis of FDA Warning Letters" aims to teach marketers how to avoid breaching current Food and Drug Administration (FDA) guidelines in their online drug promotion. While Kim hopes to minimise the potential for online promotion to misinform consumers and the study is carefully conducted, teaching drug marketers how to avoid the common mistakes in online drug promotion is more likely to make… Expand
Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries.
  • Hyosun Kim
  • Medicine
  • International journal of health policy and management
  • 2016
TLDR
Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters. Expand
Actors in whitespace: Communicating risk information on pharmaceutical websites
TLDR
Actors communicating risk information on a pharmaceutical website do not appear to improve consumers’ understanding of prescription drug information. Expand
Primary Messages of DTC Advertising during the Product Life Cycle: A Case Study
  • Scott A. Mogull
  • Computer Science, Business
  • 2018 IEEE International Professional Communication Conference (ProComm)
  • 2018
Direct-to-consumer (DTC) advertising, or the direct marketing of pharmaceutical drugs to health care consumers, is a controversial form of technical marketing communication that centers on theExpand
The Routledge Companion to Health Humanities
The health humanities is a rapidly rising field, advancing an inclusive, democratizing, activist, applied, critical, and culturally diverse approach to delivering health and well-being through theExpand

References

SHOWING 1-10 OF 16 REFERENCES
Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
  • Hyosun Kim
  • Medicine
  • International journal of health policy and management
  • 2015
TLDR
Of the total 179 violations, the majority of the alleged violations were concerned with the lack of risk information and/or misrepresentation of efficacy information, suggesting that achieving a fair balance of benefit versus risk information is a major problem with regard to the direct-to-consumer advertising of prescription drugs. Expand
Direct-to-Consumer Advertising of Prescription Medicines: A Systematic Review of the Evidence from the Perspective of the Consumer
Direct-to-consumer advertising of prescription medicines (DTCA) is a controversial practice where many of the arguments for and against are not supported by strong evidence. There is little researchExpand
It’s Time to Shine the Light on Direct-to-Consumer Advertising
TLDR
This work advocates for greater DTCA transparency, especially in the emerging digital forms of D TCA, to complement forthcoming sunshine transparency data and allow more robust study and understanding of changes in overall pharmaceutical marketing trends and their impact on health care consumption and behavior. Expand
Direct‐to‐consumer advertising under the radar: the need for realistic drugs policy in Australia
TLDR
It is argued that successful regulation of the practice of DTCA‐PM has been undermined as a result of changes brought about by the ongoing communications revolution, the increasing centrality of patient choice in medical decision‐making and the impossibility of drawing and maintaining a sharp distinction between information and advertising. Expand
Drug promotion in Australia: policy contestation and the tightening of regulation
While consumers have long been assumed to be in need of protection from drug promotion, it is now accepted that marketing to medical professionals should also be more closely controlled. PublicExpand
Direct-to-Consumer Advertising (Dtca) of Pharmaceuticals: An Updated Review of the Literature and Debate Since 2003
"The pharmaceutical sector is unusual amongst global regulated industries inasmuch as it is usually forbidden from advertising to the users of its products. This paper reports on research updating myExpand
Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?
  • C. L. Ventola
  • Medicine
  • P & T : a peer-reviewed journal for formulary management
  • 2011
TLDR
There are currently several types of DTC drug advertisements; this type may provide information about strength, dosage form, or price, but it doesn’t mention the indication or make any claims. Expand
Pharmaceutical companies are writing the script for health consumerism
In this rhetorical analysis based on the Foucaultian constructs of power in medicine, specifically the docile body, the medical gaze, and health consumerism, the authors examine ways theExpand
The informative and persuasive components of pharmaceutical promotion
The objective of this paper is to review the literature on pharmaceutical promotion, highlighting the areas of contention. We examine the traditional methods used to promote pharmaceutical productsExpand
A Prompt to the Web: The Media and Health Information Seeking Behaviour
TLDR
The survey results show that consumers become aware of medicines through traditional media and then to learn more often turn to the internet where quality of information may be poor. Expand
...
1
2
...